HTFL Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-3.090.0% YoY
Profit margin-58.4%HEALTHCARE
Market cap$2.87BMid cap
Wall Street coverage
$37.00median target· current $28.75 (+28.7%)7 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 9.91
- P/S (TTM)
- 15.04
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -135.3%
- Operating margin
- -41.9%
- Revenue growth YoY
- 41.3%
- Dividend yield
- —
- Beta
- —
Last earnings
May 15, 2026 · Estimate $-0.17 · Reported $-0.16
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Heartflow, Inc. Common Stock
Company profileHeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases globally. The company is headquartered in Mountain View, California.
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 135 MAIN STREET, SAN FRANCISCO, CA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$2.87B
Shares outstanding$86.2M
52W high$41.22
52W low$19.00
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent